Sanofi: Sarilumab reports positive results in three more phase III trials

BUY, Fair Value EUR106 (+16%)
News published on May Thursday 21, 2015
Share on

The Essentials

Everything you need to know about investment banking dedicated to growth
Stay Informed
Get our news
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities